Component
Chondrogenic, osteogenic and myogenic readouts in the 2026 combination study
Chondrogenic, osteogenic and myogenic readouts in the 2026 combination study
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
The combined preparation improved chondrogenic matrix, osteogenic mineralization and myogenic differentiation readouts in the reported stress models.
Experimental context and source evidence
- evidence_access
- Primary main-text Results and figure descriptions reviewed. Detailed supporting Methods/supplements inaccessible; exact doses and preparation details not independently extracted.
- experimental_condition
- Stressed differentiation controls co-administered · Apigenin Condition belongs to the full experimental contrast; do not separate a joint intervention.
- experimental_condition
- Stressed differentiation controls NMN plus apigenin · NMN plus apigenin preparation in the 2026 musculoskeletal study Condition belongs to the full experimental contrast; do not separate a joint intervention.
- experimental_condition
- Stressed differentiation controls co-administered · NMN Condition belongs to the full experimental contrast; do not separate a joint intervention.
- experimental_contrast
- {"intervention": "NMN plus apigenin", "comparator": "Stressed differentiation controls", "endpoint": "The combined preparation improved chondrogenic matrix, osteogenic mineralization and myogenic differentiation readouts in the reported stress models.", "effect_direction": "increase", "combination": "joint", "conditions": [{"entity_slug": "nmn-apigenin-combination-2026", "state": "NMN plus apigenin"}, {"entity_slug": "nmn", "state": "co-administered"}, {"entity_slug": "apigenin", "state": "co-administered"}]} Explicit extracted experimental comparison; recorded from source.
- experimental_model
- SOX9/COL2A1, ALP/calcium nodules/RUNX2/SP7/OCN, and MyoD1/MYOG/myotube endpoints.
- interpretation_status
- Recorded from source with stated access limits; ungraded, not independent replication.
- limitations
- Limited to the recorded preparation, model, exposure and endpoint. Does not establish a human dietary deficiency, clinical benefit or unique molecular mediation.
- nutrient_topic
- Apigenin collection; exact intervention and molecular form govern interpretation. · Apigenin
- plain_language
- The combined preparation improved chondrogenic matrix, osteogenic mineralization and myogenic differentiation readouts in the reported stress models.
- primary_references
- Double-Pronged NAD Preservation: Delaying Cellular Senescence and Initiating Musculoskeletal Regeneration. | https://pubmed.ncbi.nlm.nih.gov/41944220/ | https://pmc.ncbi.nlm.nih.gov/articles/PMC13054677/ | https://doi.org/10.1111/acel.70468
- source_locator
- Reviewed reference api-nmn-differentiation; These are model-specific readouts, not proof that apigenin increases systemic calcium or cures human musculoskeletal disease.
Apigenin: detailed mechanisms of action (reviewed 10 October 2026) · lines 540–546
AI-assisted original curation of primary studies; claim-local access and experimental limitations stated. Includes original-draft correction history. No independent replication claimed. · supports · SOX9/COL2A1, ALP/calcium nodules/RUNX2/SP7/OCN, and MyoD1/MYOG/myotube endpoints. · Recorded from source · Recorded from source
### api-nmn-differentiation The combined preparation improved chondrogenic matrix, osteogenic mineralization and myogenic differentiation readouts in the reported stress models. These are model-specific readouts, not proof that apigenin increases systemic calcium or cures human musculoskeletal disease. Model and exposure: SOX9/COL2A1, ALP/calcium nodules/RUNX2/SP7/OCN, and MyoD1/MYOG/myotube endpoints. Limitations: Limited to the recorded preparation, model, exposure and endpoint. Does not establish a human dietary deficiency, clinical benefit or unique molecular mediation. Reference: Double-Pronged NAD Preservation: Delaying Cellular Senescence and Initiating Musculoskeletal Regeneration. | 2026 | https://pubmed.ncbi.nlm.nih.gov/41944220/ | https://pmc.ncbi.nlm.nih.gov/articles/PMC13054677/ | https://doi.org/10.1111/acel.70468 | Access: Primary main-text Results and figure descriptions reviewed. Detailed supporting Methods/supplements inaccessible; exact doses and preparation details not independently extracted.
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.